Journal of Clinical Immunology

, Volume 17, Issue 1, pp 43–52 | Cite as

Early Levels of CD4, Neopterin, and β2-Microglobulin Indicate Future Disease Progression

  • Minggao Shi
  • Jeremy M. G. Taylor
  • John L. Fahey
  • Donald R. Hoover
  • Alvaro Muñoz
  • Lawrence A. Kingsley


Reduced CD4 T cell level and increased serum neopterin and β2-microglobulin levels, which reflect immunological activation and dysregulation, are three important markers of HIV disease. The aim in this study is to delineate more clearly the relation of activation to future CD4 values and disease progression. By analyzing a cohort of 198 seroconverters from the Multicenter AIDS Cohort Study with 9 years' follow-up, the dynamic changes and levels of these three markers and their interrelationships are explored. We observed that the levels of markers in the first year after seroconversion have a much stronger impact on the progression of the disease than the preseroconversion marker levels. The actual change during the year after seroconversion is not as important as the final level reached during that year. The early levels of markers after seroconversion appear to be good indicators of the subsequent course of disease as defined by CD4 level and slightly better than the quantitative changes following seroconversion or the changes in the period 1 to 2.5 years after seroconversion. To investigate the variation between subjects, the 198 seroconverters were stratified into three approximately equal-sized groups in 12 ways based on their pre- and postseroconversion levels and changes in the three markers. The group with the highest CD4 level within a year after seroconversion maintains the highest CD4 level 8 years after seroconversion. The group with the lowest level of neopterin or β2-microglobulin in this period has much higher future CD4 counts than the other two groups. The level of markers during the first year after seroconversion has a high predictive power for AIDS onset. Substantial differences in the hazards of AIDS are found between the groups with the highest and lowest CD4 count, neopterin, and β2-microglobulin following seroconversion. The three markers are generally correlated throughout the postseroconversion period but can provide distinct information. High current levels of neopterin or β2-microglobulin tend to be associated with low future CD4 count, while current levels of CD4 count have less association with future neopterin and β2-microglobulin levels.

CD4 T cell neopterin β2-microglobulin AIDS hazard correlation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Taylor JMG, Cumberland WG, Sy JP: A stochastic model for analysis of longitudinal AIDS data. J Am Statist Assoc 89:727–736, 1994Google Scholar
  2. 2.
    Hofmann B, Wang Y, Cumberland WG, Detels R, Bozorgmehri M, Fahey J: Serum beta-2 microglobulin level increases in HIV infection: Relation to seroconversion, CD4 T-cell fall and prognosis. AIDS 4:207–214, 1990Google Scholar
  3. 3.
    Melmed RN, Taylor JMG, Detels R, Bozorgmehri M, Fahey JL: Serum neopterin changes in HIV-infected subjects: Indicator of significant pathology, CD4 T cell changes, and the development of AIDS. J AIDS 2:70–76, 1989Google Scholar
  4. 4.
    Fuchs D, Spria TJ, Harrsen A, Reibnegger G, Werner ER, Werner-Felmayer G, Wachter H: Neopterin as a predictive marker for disease progression in human immunodeficiency virus type 1 infection. Clin Chem 35:1746–1749, 1989Google Scholar
  5. 5.
    Moss AR, Bachetti P: Natural history of HIV infection. AIDS 3:55–61, 1989Google Scholar
  6. 6.
    Sheppard HW, Lang W, Ascher MS, Vittinghoff E, Winkelstein W: The characterization of non-progressors: Long-term HIV-1 infection with stable CD4+ T-cell levels. AIDS 7:1159–1166, 1993Google Scholar
  7. 7.
    Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD: Long-term HIV-1 infection without immunologic progression. AIDS 8:1123–1128, 1994Google Scholar
  8. 8.
    Phair J, Muñoz A, Detels R, Kaslow R, Rinaldo C, Saah A: The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. N Engl J Med 322:161–165, 1990Google Scholar
  9. 9.
    Fahey JL, Taylor JMG, Detels R, Hofmann B, Melmed R, Nishanian P, Giorgi JV: The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 322:166–172, 1990Google Scholar
  10. 10.
    Sheppard HW, Ascher MS, McRae B, Anderson RE, Lang W, Allain JP: The initial immune response to HIV and immune system activation determine the outcome of HIV disease. J AIDS 4:704–712, 1991Google Scholar
  11. 11.
    Pantaleo G, Fauci AS: New concepts in the immunopathogenesis of HIV infection. Annu Rev Immunol 15:487–512, 1995Google Scholar
  12. 12.
    Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D, Reibnegger G, Swetly P, Troppmair J, Wachter H: Immune response-associated production of neopterin: Release from macrophages primarily under control of interferon-gamma. J Exp Med 160:310–316, 1984Google Scholar
  13. 13.
    Poli G, Kinter A, Justement JS, Kehrl JH, Bressler P, Stanley S, Fauci AS: Tumor necrosis factor α functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sci USA 87:782–785, 1990Google Scholar
  14. 14.
    Salazar-Gonzalez JF, Martinez-Maza O, Aziz N, Kolberg JA, Yeghiazarian T, Shen LP, Fahey JL: Plasma HIV-RNA levels correlate with TNFα and soluble TNF receptor levels in HIV infection (submitted for publication), 1996Google Scholar
  15. 15.
    Margolick JB, Muñoz A, Donnenberg AD, Park LP, Galai N, Giorgi JV, O'Gorman MRG, Ferbas J: Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. Nature Med 1:674–680, 1995Google Scholar
  16. 16.
    Lang W, Perkins H, Anderson RE, Royce R, Jewell N, Winkelstin W Jr: Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J AIDS 2:63–69, 1989Google Scholar
  17. 17.
    Vittinghoff E, Malani HM, Jewell NP: Estimating patterns of CD4 lymphocyte decline using data from a prevent cohort of HIV infected individuals. Stat Med 13:1100–1118, 1994Google Scholar
  18. 18.
    Jurrians S, Van Gemen B, Weverling GJ: The natural history of HIV-1 infection: Virus load and virus phenotype independent determinants of clinical course? Virology 204:223–233, 1994Google Scholar
  19. 19.
    Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH, Saag MS, Shaw GM: Viral dynamics in human immunodeficiency virus type-1 infection. Nature 373:117–123, 1995Google Scholar
  20. 20.
    Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123–126, 1995Google Scholar
  21. 21.
    O'Brien WA, Hartigan PM, Martin D, Esinhart J, Hill A, Benoit S, Rubin M, Simberkoff MF, Hamilton JD: Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. N Engl J Med 334:426–438, 1996Google Scholar
  22. 22.
    Mellors JW, Kingsley LA, Rinaldo CR, Todd JA, Hoo BS, Kokka RP, Gupta P: Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 122:573–579, 1995Google Scholar
  23. 23.
    O'Brien TR, Blattner WA, Waters D, Eyster ME, Hilgartner MW, Cohen AR, Luban N, Hatzakis A, Aledort LM, Rosenberg PS, Miley WJ, Kroner BL, Goedert JJ: Serum HIV-1 RNA levels and time to the development of AIDS in the multicenter Hemophilia Cohort Study. J Am Med Assoc 276:105–110, 1996Google Scholar
  24. 24.
    Galai N, Muñoz A, Chen K, Carey VJ, Chmiel J, Zhou SY: Tracking of markers and onset of disease among HIV-1 seroconverters. Stat Med 12:2133–2145, 1993Google Scholar
  25. 25.
    Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR: The Multicenter AIDS Cohort Study: Rational, organization, and selected characteristic of the participants. Am J Epidemiol 126:310–318, 1987Google Scholar
  26. 26.
    Foulkes MA, Davis CE: An index of tracking for longitudinal data. Biometrics 44:959–971, 1981Google Scholar
  27. 27.
    Shi M, Weiss R, Taylor JMG: An analysis of pediatric CD4 counts for acquired immune deficiency syndrome using flexible random curves. Appl Stat 45:151–164, 1996Google Scholar
  28. 28.
    Easterbrook PJ: Non-progression in HIV infection. AIDS 8:1179–1182, 1994Google Scholar
  29. 29.
    Taylor JMG, Sy JP, Visscher B, Giorgi JV: CD4+ T-cell number at the time of acquired immunodeficiency syndrome. Am J Epidemiol 141(7):645–651, 1995Google Scholar
  30. 30.
    Simmonds P, Beatson D, Cuthbert RJG, Watson H, Reynolds B, Peutherer JF, Parry JV, Ludlam CA, Steel CM: Determinants of HIV disease progression: Six-year longitudinal study in the Edinburgh haemophilia/HIV cohort. Lancet 338:1159–1163, 1991Google Scholar

Copyright information

© Plenum Publishing Corporation 1997

Authors and Affiliations

  • Minggao Shi
    • 1
  • Jeremy M. G. Taylor
    • 1
  • John L. Fahey
    • 2
  • Donald R. Hoover
    • 3
  • Alvaro Muñoz
    • 3
  • Lawrence A. Kingsley
    • 4
  1. 1.Department of BiostatisticsUCLA School of Public HealthLos Angeles
  2. 2.Department of Microbiology and ImmunologyUCLA School of MedicineLos Angeles
  3. 3.Department of EpidemiologyJohns Hopkins University School of Hygiene and Public HealthBaltimore
  4. 4.Department of Infectious Diseases and MicrobiologyUniversity of PittsburghPittsburgh

Personalised recommendations